Clinical Trial Update: A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating GLIADEL wafers versus stereotactic radiosurgery for metastatic brain tumors and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• GLIADEL wafer (carmustine)

Snippet

Sponsor: University of Nebraska | Conditions: Brain Tumor - Metastatic | Phase 2 | Status: RECRUITING